Cholestanol promotes tau pathology in a mouse model of tauopathy

Ting Yu, Yuanmin Li, Sheng Li, Shuke Nie, Hongyan Feng, Zhentao Zhang, Lanxia Meng · 2025

Read Cholestanol promotes tau pathology in a mouse model of tauopathy by Ting Yu, Yuanmin Li, Sheng Li, Shuke Nie, Hongyan Feng, Zhentao Zhang, Lanxia Meng (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12738505.txt.

Description

Ting Yu and co-authors show that a cholesterol-like compound worsens tau damage in a mouse model of tau disease, in a 2025 study. The compound, cholestanol, builds up in a rare inherited lipid disorder whose patients often lose cognitive ability. The team also found higher cholestanol levels in the blood of Alzheimer patients than in controls, which raised the question of a direct role.

In their tests, the compound switched on an enzyme that cuts tau protein and adds phosphate tags, both steps in tau pathology. Silencing that enzyme eased the damage the compound caused. Feeding the compound to mice bred for tau disease worsened their tau pathology and behaviour, while removing the enzyme protected them. The authors single out the enzyme as a drug target for Alzheimer disease, above all for patients whose blood cholestanol runs high.

Catalog record

CREATORTing Yu, Yuanmin Li, Sheng Li, Shuke Nie, Hongyan Feng, Zhentao Zhang, Lanxia Meng
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE59 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC12738505

Browse the full library · About the Tower of Babel